Robb Evans
About Robb Evans
Robb Evans is an Oncology Account Specialist currently working at Accord BioPharma since 2022. He has extensive experience in the pharmaceutical industry, having held various roles at companies such as Auxilium Pharmaceuticals, Bayer HealthCare, and Exact Sciences.
Work at Accord BioPharma
Robb Evans has been employed at Accord BioPharma as an Oncology Account Specialist since 2022. In this role, he focuses on promoting therapies for oncology patients, specifically advanced prostate cancer. His contributions include the recent launch of a new therapy aimed at treating this condition. Evans has demonstrated significant performance, finishing the 22/23 year as the top Oncology Account Specialist in the country, leading in both volume and percent to goal.
Previous Experience in Pharmaceuticals
Robb Evans has a diverse background in the pharmaceutical industry, having held several positions prior to his current role. He worked as a Medical Sales Consultant at Auxilium Pharmaceuticals from 2010 to 2013, where he was recognized for receiving the first order of Camcevi. His career also includes roles at Bayer HealthCare as a Pharmaceutical Sales Representative from 2002 to 2004, and at Exact Sciences as a Regional Urogenomic Liaison from 2020 to 2022. Additionally, he served as a Territory Manager at Coloplast from 2014 to 2017 and as an Oncology Specialty Consultant at Syneos Health for a brief period in 2017.
Education and Qualifications
Robb Evans earned a Bachelor of Science (BS) degree in Advertising from Bradley University. This educational background has provided him with a foundation in communication and marketing strategies, which are essential in his roles within the pharmaceutical sales sector.
Achievements in Sales
Throughout his career, Robb Evans has received notable recognition for his sales performance. He was the inaugural winner of the President’s Club award, highlighting his exceptional contributions to sales within his organizations. His ability to lead in sales metrics is further evidenced by his recent achievement as the #1 Oncology Account Specialist in the country for the 22/23 year.